AI Article Synopsis

  • A 59-year-old man presented with a large gastric gastrointestinal stromal tumor (GIST) that was previously non-resectable due to its invasion into surrounding organs.
  • After administering neoadjuvant chemotherapy with imatinib mesylate, a significant reduction in tumor size was observed after six months.
  • Following the reduction, the tumor was deemed resectable, leading to partial gastrectomy and splenectomy, resulting in a pathological complete response with no viable tumor cells detected.

Article Abstract

We report a case of a large gastric gastrointestinal stromal tumor (GIST), which became resectable and achieved pathological complete response after neoadjuvant chemotherapy with imatinib mesylate. A 59-year-old man presented with left hypochondrial pain. Abdominal computed tomography (CT) revealed gastric GIST invading the spleen and the diaphragm. Administration of imatinib mesylate was initiated as neoadjuvant chemotherapy. Six months after neoadjuvant chemotherapy with imatinib mesylate, abdominal CT revealed a reduction in tumor size. We judged the tumor resectable and performed partial gastrectomy and splenectomy. Histologically, number of myofibroblasts increased, but no viable tumor cells were observed. Pathological complete response was obtained.

Download full-text PDF

Source

Publication Analysis

Top Keywords

neoadjuvant chemotherapy
16
complete response
12
chemotherapy imatinib
12
imatinib mesylate
12
large gastric
8
gastric gist
8
gist resectable
8
pathological complete
8
[pathological complete
4
response large
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!